Yirui Kuang

Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Retraction notice to "miR-33b in human cancer: Mechanistic and clinical perspectives" [Biomedicine & Pharmacotherapy 161 (2023) 114432].

Retraction notice to "miR-33b in human cancer: Mechanistic and clinical perspectives" [Biomedicine & Pharmacotherapy 161 (2023) 114432].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 18, 2026

Clinical, molecular characteristics, and telomere-maintaining mechanism of spinal cord glioma with or without H3 K27M mutation: a prognostic and experimental study.

Clinical, molecular characteristics, and telomere-maintaining mechanism of spinal cord glioma with or without H3 K27M mutation: a prognostic and experimental study.

Journal: International journal of surgery (London, England)

Published: July 16, 2025

Pan-cancer analysis and experimental validation revealed that prognostic biomarker APOBEC3C may promote M2-type macrophage polarization and prevent R-loop accumulation in glioma.

Pan-cancer analysis and experimental validation revealed that prognostic biomarker APOBEC3C may promote M2-type macrophage polarization and prevent R-loop accumulation in glioma.

Journal: International journal of biological macromolecules

Published: February 12, 2025

Integrated profiling identifies ferredoxin 1 as an immune-related biomarker of malignant phenotype in glioma.

Integrated profiling identifies ferredoxin 1 as an immune-related biomarker of malignant phenotype in glioma.

Journal: Heliyon

Published: October 03, 2023

Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma.

Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma.

Journal: Frontiers in immunology

Published: September 14, 2023

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients.

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients.

Journal: Frontiers in immunology

Published: January 05, 2023

miR-33b in human cancer: Mechanistic and clinical perspectives.

miR-33b in human cancer: Mechanistic and clinical perspectives.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 29, 2022

The research landscape of immunology research in spinal cord injury from 2012 to 2022.

The research landscape of immunology research in spinal cord injury from 2012 to 2022.

Journal: JOR spine

Published: December 11, 2022

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.

Journal: Frontiers in immunology

Published: November 18, 2022

The role of lncRNA just proximal to XIST (JPX) in human disease phenotypes and RNA methylation: The novel biomarker and therapeutic target potential.

The role of lncRNA just proximal to XIST (JPX) in human disease phenotypes and RNA methylation: The novel biomarker and therapeutic target potential.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 10, 2022

A practical and economical method for frontal sinus reconstruction after frontal craniotomy: A single-center experience with 140 patients.

A practical and economical method for frontal sinus reconstruction after frontal craniotomy: A single-center experience with 140 patients.

Journal: Frontiers in surgery

Published: April 29, 2022

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis.

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis.

Journal: Cancer cell international

Published: March 22, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026